Bhatia Sangeeta N.
SEC insider (Form 3/4/5 filer). CIK 0001643921. Director at VERTEX PHARMACEUTICALS INC / MA (VRTX). 8 reported Form 4/5 transactions since Sep 2024; latest on May 4, 2026. Located in BOSTON, MA.
Companies Bhatia Sangeeta N. has filed insider reports for
- VERTEX PHARMACEUTICALS INC / MA (VRTX): Director
Bhatia Sangeeta N.
CIK: 0001643921
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VERTEX PHARMACEUTICALS INC / MA
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- May 4, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect318 shares at avg. $423.73$135K - May 1, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
AwardDirect943 shares- - Feb 13, 2026VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect266 shares at avg. $500.00$133K - Aug 27, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect266 shares at avg. $386.69$103K - May 2, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect400 shares at avg. $505.86$202K - May 1, 2025VRTX
VERTEX PHARMACEUTICALS INC / MA
AwardDirect796 shares- - Aug 30, 2024VRTX
VERTEX PHARMACEUTICALS INC / MA
ExerciseDirect646 shares at avg. $152.74$99K - Aug 30, 2024VRTX
VERTEX PHARMACEUTICALS INC / MA
SaleDirect646 shares at avg. $500.00$323K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 4, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 318 | $423.73 | $134,746 | Direct |
| May 1, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Award | 943 | - | $0 | Direct |
| Feb 13, 2026 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 266 | $500.00 | $133,000 | Direct |
| Aug 27, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 266 | $386.69 | $102,860 | Direct |
| May 2, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 400 | $505.86 | $202,344 | Direct |
| May 1, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | Award | 796 | - | - | Direct |
| Aug 30, 2024 | VRTX VERTEX PHARMACEUTICALS INC / MA | Exercise | 646 | $152.74 | $98,670 | Direct |
| Aug 30, 2024 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sale | 646 | $500.00 | $323,000 | Direct |
1-8 of 8 transactions